Application
Fig1: Western blot analysis of DR5 on HL-60 cell using anti-DR5 antibody at 1/1,000 dilution.Application
Fig2: Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-DR5 antibody. Counter stained with hematoxylin.Application
Fig3: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-DR5 antibody. Counter stained with hematoxylin.Application
Fig4: Immunohistochemical analysis of paraffin-embedded human colon cancer tissue using anti-DR5 antibody. Counter stained with hematoxylin.Application
Fig5: Immunohistochemical analysis of paraffin-embedded human placenta tissue using anti-DR5 antibody. Counter stained with hematoxylin.Application
Fig6: Flow cytometric analysis of SW480 cells with DR5 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Product Name | DR5 [JA03-38] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | Fas like protein antibody Apoptosis inducing protein TRICK2A/2B antibody Apoptosis inducing receptor TRAIL R2 antibody CD262 antibody CD262 antigen antibody Cytotoxic TRAIL receptor 2 antibody Death domain containing receptor for TRAIL/Apo 2L antibody Death receptor 5 antibody DR5 antibody KILLER antibody KILLER/DR5 antibody OTTHUMP00000123492 antibody OTTHUMP00000123493 antibody p53 regulated DNA damage inducible cell death receptor(killer) antibody TNF related apoptosis inducing ligand receptor 2 antibody TNF-related apoptosis-inducing ligand receptor 2 antibody TNFRSF10B antibody TR10B_HUMAN antibody TRAIL R2 antibody TRAIL receptor 2 antibody TRAIL-R2 antibody TRAILR2 antibody TRICK2 antibody TRICK2A antibody TRICK2B antibody TRICKB antibody Tumor necrosis factor receptor like protein ZTNFR9 antibody Tumor necrosis factor receptor superfamily member 10B antibody Tumor necrosis factor receptor superfamily, member 10b antibody ZTNFR9 antibody |
| Product description | Tumor necrosis factor (TNF) is a pleiotropic cytokine whose function is mediated by two distinct cell surface receptors, designated TNF-R1 and TNF-R2, which are expressed on most cell types. TNF function is primarily mediated through TNF-R1 signaling. Both receptors belong to the growing TNF receptor superfamily which includes FAS antigen and CD40. TNF-R1 contains a cytoplasmic motif, termed the "death domain," that has been found to be necessary for the transduction of the apoptotic signal. The death domain is also found in several other receptors, including FAS, DR2 (or TRUNDD), DR3 (Death Receptor 3), DR4 and DR5. TRUNDD, DR4 and DR5 are receptors for the apoptosis-inducing cytokine TRAIL. A non-death domain-containing receptor, designated decoy receptor (DcR1 or TRID), also specifically associates with TRAIL and may play a role in cellular resistance to apoptotic stimuli. |
| Immunogen | recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG |
| Host Species | Recombinant rabbit |
| Tested Applications | WBIPIHCFC |
| WB:1:500-1:1,000 IHC:1:50-1:200 FC:1:50-1:100 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | Fas like protein antibody
Apoptosis inducing protein TRICK2A/2B antibody
Apoptosis inducing receptor TRAIL R2 antibody
CD262 antibody
CD262 antigen antibody
Cytotoxic TRAIL receptor 2 antibody
Death domain containing receptor for TRAIL/Apo 2L antibody
Death receptor 5 antibody
DR5 antibody
KILLER antibody
KILLER/DR5 antibody
OTTHUMP00000123492 antibody
OTTHUMP00000123493 antibody
p53 regulated DNA damage inducible cell death receptor(killer) antibody
TNF related apoptosis inducing ligand receptor 2 antibody
TNF-related apoptosis-inducing ligand receptor 2 antibody
TNFRSF10B antibody
TR10B_HUMAN antibody
TRAIL R2 antibody
TRAIL receptor 2 antibody
TRAIL-R2 antibody
TRAILR2 antibody
TRICK2 antibody
TRICK2A antibody
TRICK2B antibody
TRICKB antibody
Tumor necrosis factor receptor like protein ZTNFR9 antibody
Tumor necrosis factor receptor superfamily member 10B antibody
Tumor necrosis factor receptor superfamily member 10b antibody ZTNFR9 antibody |
|---|---|
| Molecular Weight(MW) | 48 kDa |
| Cellular Localization | Membrane. |
| SwissProt ID | O14763 |
|---|
Application
Fig1: Western blot analysis of DR5 on HL-60 cell using anti-DR5 antibody at 1/1,000 dilution.
Application
Fig2: Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-DR5 antibody. Counter stained with hematoxylin.
Application
Fig3: Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-DR5 antibody. Counter stained with hematoxylin.
Application
Fig4: Immunohistochemical analysis of paraffin-embedded human colon cancer tissue using anti-DR5 antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human placenta tissue using anti-DR5 antibody. Counter stained with hematoxylin.
Application
Fig6: Flow cytometric analysis of SW480 cells with DR5 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black).| Positive Control | HL-60, human tonsil tissue, human liver tissue, human colon cancer tissue, human placenta tissue, SW480. |
|---|---|
| Application Notes | WB:1:500-1:1,000 IHC:1:50-1:200 FC:1:50-1:100 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
